Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Hypertension
Interventions
DRUG

Atenolol

100 mg tablets orally once a day (od) in the morning.

DRUG

Hydrochlorothiazide (HCTZ))

12.5 or 25 mg tablets orally once a day (od) in the morning.

DRUG

Valsartan

80 mg, 160 mg, or 320 mg tablets orally once a day in the morning

Trial Locations (2)

Unknown

Investigative Centers

Novartis Pharma Ag, Basel

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00396656 - Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients | Biotech Hunter | Biotech Hunter